Isocitrate Dehydrogenase Wild-type Glial Tumors, Including Glioblastoma.

Galanis, Evanthia; Wen, Patrick Y; de Groot, John F; Weller, Michael

Galanis, Evanthia; Wen, Patrick Y; de Groot, John F; Weller, Michael.

Afiliação

Galanis E; Department of Oncology, Mayo Clinic, 200 First Street Southwest, Rochester, MN 55905, USA. Electronic address: galanis.evanthia@mayo.edu.
Wen PY; Neuro-oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Shields Warren 430 D, Boston, MA 02215, USA.
de Groot JF; Department of Neurological Surgery, University of California San Francisco, 505 Parnassus Avenue, San Francisco, CA 94143, USA.
Weller M; Department of Neurology, University Hospital and University of Zurich, Frauenklinikstrasse 26, Zurich 8091, Switzerland.

Hematol Oncol Clin North Am ; 36(1): 113-132, 2022 02.

Article em En | MEDLINE | ID: mdl-34756799

Assuntos

Neoplasias Encefálicas; Glioblastoma; Glioma; Oligodendroglioma; Neoplasias Encefálicas/genética; Neoplasias Encefálicas/terapia; Glioblastoma/genética; Glioblastoma/terapia; Humanos; Isocitrato Desidrogenase/genética

Palavras-chave

Glioblastoma; Glioma; H3K27M mutant glioma; IDH wild-type; Pilocytic astrocytoma; Pleomorphic xanthoastrocytoma

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Oligodendroglioma / Neoplasias Encefálicas / Glioblastoma / Glioma Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google